Immunovant, Inc.
IMVT
$15.80
-$0.06-0.38%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 90.55% | -20.78% | -15.55% | -11.86% | -8.04% |
| Total Receivables | 12.90% | 18.55% | -22.38% | -56.08% | 434.79% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 43.63% | 9.45% | 22.27% | 6.92% | 32.39% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 86.08% | -18.69% | -13.87% | -11.52% | -6.33% |
|
|
|||||
| Total Current Assets | 86.08% | -18.69% | -13.87% | -11.52% | -6.33% |
| Net Property, Plant & Equipment | 21.71% | 8.10% | 13.47% | 6.05% | -11.19% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 0.01% | -0.03% | -- | -- | -- |
| Total Assets | 84.41% | -18.38% | -12.54% | -11.51% | -6.34% |
|
|
|||||
| Total Accounts Payable | -10.90% | -4.40% | 87.83% | 54.23% | 82.99% |
| Total Accrued Expenses | 4.69% | 5.66% | 35.28% | -17.88% | 48.10% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 326.09% | -51.06% | -31.88% | -50.00% | -54.90% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 0.67% | 2.49% | 48.06% | -7.39% | 51.42% |
|
|
|||||
| Total Current Liabilities | 0.67% | 2.49% | 48.06% | -7.39% | 51.42% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 0.67% | 2.49% | 48.06% | -7.39% | 51.42% |
|
|
|||||
| Common Stock & APIC | 31.17% | 0.96% | 0.92% | 0.98% | 0.78% |
| Retained Earnings | -9.39% | -10.87% | -11.95% | -10.55% | -10.04% |
| Treasury Stock & Other | -41.15% | 29.79% | 4.95% | -4.61% | 418.00% |
| Total Common Equity | 100.63% | -21.48% | -17.55% | -11.83% | -9.07% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 100.63% | -21.48% | -17.55% | -11.83% | -9.07% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 100.63% | -21.48% | -17.55% | -11.83% | -9.07% |
|
|
|||||